Advertisements



Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

23andMe eyes millions of more users with new report on diabetes

23andMe is adding a report to its health and ancestry DNA test for type 2 diabetes. That's a huge market opportunity as 1 in 3 people are at risk for developing the disease. More than 30 million people in the U.S. alone have diabetes......»»

Category: topSource: moneycentralMar 10th, 2019

Valeritas V-Go demonstrates benefits compared to MDI therapy for type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

6 simple, science-backed ways to get rid of belly fat

Shutterstock/ nd3000  Having lots of fat in the abdominal area is strongly linked to diseases like type 2 diabetes and heart disease. Excess sugar and carb consumptio.....»»

Category: topSource: businessinsiderApr 12th, 2018

MedImmune spinoff scores breakthrough status for rare autoimmune disease treatment

Viela Bio Inc. has earned a breakthrough therapy designation from the Food and Drug Administration for a product to treat neuromyelitis optica spectrum disorder, a life-threatening autoimmune disease that impacts the central nervous system. The FDA g.....»»

Category: topSource: bizjournalsApr 19th, 2019

Viela Bio scores breakthrough status for rare autoimmune disease treatment

Viela Bio Inc. has earned a breakthrough therapy designation from the Food and Drug Administration for a product to treat neuromyelitis optica spectrum disorder, a life-threatening autoimmune disease that impacts the central nervous system. The FDA g.....»»

Category: topSource: bizjournalsApr 18th, 2019

Mustang Bio Gallops Higher On Positive Gene Therapy Results For Deadly "Bubble Boy Disease"

Shares of Mustang Bio Inc (NASDAQ: MBIO) are skyrocketing to their highest level in about a year Thursday morning. read more.....»»

Category: blogSource: benzingaApr 18th, 2019

Johnson & Johnson Looks To Help Type 2 Diabetes Patients With Key Advancement

Johnson & Johnson Looks To Help Type 2 Diabetes Patients With Key Advancement.....»»

Category: topSource: seekingalphaApr 17th, 2019

A Single Tiny Change on Nutrition Labels Could Save Many Lives

Nearly a million cases of heart disease and diabetes could be prevented by the implementation of one small change on food ingredient labels. According to a study published Monday in Circulation, a........»»

Category: blogSource: 247wallstApr 16th, 2019

How food labels could cut health-care costs by more than $31 billion

More detailed food labels could reduce risks of heart disease and diabetes, lower medical costs, a new study says......»»

Category: topSource: marketwatchApr 15th, 2019

AstraZeneca"s Forxiga Gets Nod in Japan for Type I Diabetes

AstraZeneca's (AZN) Forxiga gets a.....»»

Category: worldSource: nytMar 28th, 2019

AstraZeneca reports Forxiga approved in Japan for type-1 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 27th, 2019

Lexicon Falls as FDA Denies Approval to Type I Diabetes Drug

FDA issues complete response letter for Lexicon Pharmaceuticals (LXRX) and partner Sanofi's marketing application for .....»»

Category: dealsSource: nytMar 25th, 2019

AstraZeneca reports Forxiga approved in Europe for type-1 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2019

Axovant jumps following update on Tay-Sachs Disease gene therapy program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 11th, 2019

CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study

CRISPR Therapeutics (CRSP) and partner Vertex start dosing of beta thalassemia patients in an early-stage study evaluating gene editing therapy, CTX001. Initiates enrollment in sickle cell disease study. .....»»

Category: smallbizSource: nytFeb 26th, 2019

Roche bids $4.8B for Spark and its gene therapy

Roche Holding AG will buy Spark Therapeutics Inc. for $4.8 billion, a deal that will give the Swiss drugmaker one of the first-ever therapies to treat, and potentially cure, a disease by providing a fix for a patient’s defective genes......»»

Category: topSource: moneycentralFeb 25th, 2019

Veterinary Therapeutics is committed to the timely dispersal of crucial research findings(Vet Therapeut)

Veterinary therapeutics is a type of medical science that deals with protection of health, alleviation, prevention, and remedy of disease and injury in both companion animals as well as wild animals. read more.....»»

Category: blogSource: benzingaFeb 21st, 2019

Intercept Pharmaceuticals is one step closer to getting FDA approval for the first-ever NASH drug

Intercept Pharmaceuticals Inc. announced Tuesday that a potential therapy for the fatty liver disease known as NASH had achieved its primary goal in a Phase 3 trial, a week after Gilead Sciences Inc. announced a competing trial had failed......»»

Category: topSource: marketwatchFeb 19th, 2019

Nearly Half of All U.S. Adults Have Some Form of Cardiovascular Disease

The vast majority have high blood pressure, or hypertension. Nearly half of all U.S. adults have some type of cardiovascular disease, with the vast majority suffering from high blood pressure, sta.....»»

Category: europeSource: fortuneJan 31st, 2019

MeiraGTx partnering with Janssen to develop and market retinal disease therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2019